Woodline Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.63M Sell
73,286
-171,168
-70% -$15.7M 0.03% 606
2025
Q4
$22M Buy
244,454
+3,624
+2% +$344K 0.09% 291
2025
Q3
$23.7M Sell
240,830
-240,000
-50% -$23.8M 0.11% 247
2025
Q2
$43.9M Buy
480,830
+326
+0.1% +$31.5K 0.23% 123
2025
Q1
$54.4M Sell
480,504
-482,403
-50% -$51.6M 0.35% 74
2024
Q4
$102M Buy
962,907
+45,980
+5% +$4.93M 0.69% 13
2024
Q3
$99M Sell
916,927
-275
-0% -$30K 0.83% 21
2024
Q2
$99.5M Buy
917,202
+1,852
+0.2% +$218K 0.95% 15
2024
Q1
$121M Buy
915,350
+358,631
+64% +$44.8M 1.11% 9
2023
Q4
$67.8M Hold
556,719
0.74% 32
2023
Q3
$62.5M Buy
556,719
+181,116
+48% +$23M 0.73% 29
2023
Q2
$54.7M Sell
375,603
-296,604
-44% -$40.3M 0.65% 37
2023
Q1
$86.8M Buy
672,207
+130,059
+24% +$16.3M 1.18% 10
2022
Q4
$69.1M Buy
542,148
+157,972
+41% +$18.3M 0.92% 14
2022
Q3
$40.2M Buy
384,176
+98,814
+35% +$10.8M 0.56% 32
2022
Q2
$30M Sell
285,362
-1,323
-0.5% -$157K 0.46% 54
2022
Q1
$36.7M Buy
286,685
+162,894
+132% +$19.6M 0.6% 38
2021
Q4
$15.3M Buy
123,791
+34,903
+39% +$4.57M 0.22% 129
2021
Q3
$12.6M Buy
+88,888
New +$13.1M 0.21% 136
2021
Q2
Sell
-361,194
Closed -$56.1M 632
2021
Q1
$56.1M Buy
361,194
+279,456
+342% +$43.3M 1.25% 9
2020
Q4
$12.2M Sell
81,738
-153,664
-65% -$21.7M 0.32% 93
2020
Q3
$31.1M Sell
235,402
-24,812
-10% -$3.24M 1.02% 31
2020
Q2
$30.2M Buy
+260,214
New +$30M 1.19% 27
2020
Q1
Sell
-194,997
Closed -$28.3M 175
2019
Q4
$28.3M Buy
+194,997
New +$26.9M 1.16% 33

Other funds holding ZBH

Woodline Partners's ZBH Position: Q1 2026 in Review

Woodline Partners reduced its Zimmer Biomet (ZBH) stake by 70% in Q1 2026, selling an estimated $15.7M and leaving 73,286 shares worth $6.63M. The position accounts for 0.03% of the portfolio, ranked #606.

Woodline Partners first reported a position in ZBH in Q4 2019 and has held it in 24 quarters since. The position peaked at $121M in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Woodline Partners held 73,286 shares of Zimmer Biomet worth $6.63M as of Q1 2026.
  • Woodline Partners sold 171,168 Zimmer Biomet shares in Q1 2026, an estimated $15.7M.
  • Zimmer Biomet made up 0.03% of Woodline Partners's portfolio in Q1 2026, its #606 holding.
  • Woodline Partners first reported a position in Zimmer Biomet in Q4 2019 and has held it in 24 quarters since.
  • Woodline Partners's Zimmer Biomet position peaked at $121M in Q1 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.